Stempoint Capital LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Stempoint Capital LP disclosed 48 US equity positions worth $398.7m in its Q4 2024 13F filing. The largest position was SNDX at 9.5% of the reported book, followed by ROIV and IMVT. Against the Q3 2024 filing, it opened 22 new positions, added to 18 and reduced 6 among the top 48 holdings.
What did Stempoint Capital LP own in Q4 2024? Top 48 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 9.5% | $38.0m | 2,872,601 | 66% | added |
| 2 | ROIV ROIVANT SCIENCES LTD | Healthcare | 8.0% | $32.1m | 2,712,778 | -2% | reduced |
| 3 | IMVT IMMUNOVANT INC | Healthcare | 6.9% | $27.7m | 1,118,508 | 67% | added |
| 4 | MERUS N V | 6.5% | $25.9m | 614,812 | 46% | added | |
| 5 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 4.1% | $16.2m | 317,060 | 48% | added | |
| 6 | XENE XENON PHARMACEUTICALS INC | Healthcare | 3.7% | $14.7m | 375,845 | – | new |
| 7 | INCY INCYTE CORP | Healthcare | 3.4% | $13.4m | 193,623 | 50% | added |
| 8 | ALKS ALKERMES PLC | Healthcare | 3.0% | $12.0m | 416,968 | 752% | added |
| 9 | DNLI DENALI THERAPEUTICS INC | Healthcare | 3.0% | $11.9m | 584,328 | 107% | added |
| 10 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 2.9% | $11.6m | 208,016 | 404% | added |
| 11 | NUVALENT INC | 2.9% | $11.4m | 145,234 | – | new | |
| 12 | CNTA CENTESSA PHARMACEUTICALS PLC | 2.7% | $10.8m | 641,964 | 667% | added | |
| 13 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.6% | $10.3m | 134,178 | -23% | reduced |
| 14 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 2.4% | $9.4m | 166,068 | -40% | reduced |
| 15 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 2.2% | $8.9m | 721,209 | 140% | added |
| 16 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.1% | $8.5m | 193,535 | 1062% | added |
| 17 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.1% | $8.4m | 992,803 | – | new | |
| 18 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.0% | $7.8m | 145,876 | 195% | added |
| 19 | INSM INSMED INC | Healthcare | 1.8% | $7.4m | 106,610 | – | new |
| 20 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.8% | $7.2m | 166,307 | – | new |
| 21 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.8% | $7.0m | 949,401 | – | new |
| 22 | BNTX BIONTECH SE | Healthcare | 1.8% | $7.0m | 61,403 | – | new |
| 23 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 1.8% | $7.0m | 500,966 | -72% | reduced |
| 24 | BHVN BIOHAVEN LTD | Healthcare | 1.7% | $7.0m | 186,413 | -14% | reduced |
| 25 | VTGN VISTAGEN THERAPEUTICS INC | 1.5% | $5.9m | 2,328,492 | 26% | added | |
| 26 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.4% | $5.5m | 141,714 | – | new |
| 27 | ACELYRIN INC | 1.3% | $5.4m | 1,704,825 | 29% | added | |
| 28 | SRZN SURROZEN INC | 1.3% | $5.0m | 350,573 | 92% | added | |
| 29 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.2% | $4.9m | 400,101 | – | new |
| 30 | NMRA NEUMORA THERAPEUTICS INC. | Healthcare | 1.1% | $4.5m | 428,137 | – | new |
| 31 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.1% | $4.3m | 579,500 | – | new |
| 32 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.1% | $4.3m | 101,809 | – | new |
| 33 | ETNBGBP 89BIO INC | 1.1% | $4.3m | 545,800 | – | new | |
| 34 | CYTK CYTOKINETICS INC | Healthcare | 1.0% | $3.9m | 83,576 | 478% | added |
| 35 | CTNM CONTINEUM THERAPEUTICS INC | 1.0% | $3.9m | 265,833 | – | new | |
| 36 | EWTX EDGEWISE THERAPEUTICS INC | 0.9% | $3.5m | 132,706 | 567% | added | |
| 37 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.9% | $3.4m | 270,983 | – | new |
| 38 | JSPR JASPER THERAPEUTICS INC | 0.7% | $2.9m | 135,244 | – | new | |
| 39 | TRML TOURMALINE BIO INC | 0.6% | $2.6m | 126,400 | 128% | added | |
| 40 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.5% | $2.2m | 96,716 | – | new |
| 41 | HELIX ACQUISITION CORP II | 0.5% | $2.1m | 200,900 | 0% | held | |
| 42 | TARA PROTARA THERAPEUTICS INC | 0.4% | $1.8m | 332,394 | -65% | reduced | |
| 43 | QURE UNIQURE NV | 0.4% | $1.6m | 90,000 | – | new | |
| 44 | PERCEPTIVE CAP SOLUTIONS COR | 0.4% | $1.5m | 150,000 | 0% | held | |
| 45 | VRNA VERONA PHARMA PLC | 0.3% | $1.3m | 28,136 | – | new | |
| 46 | CDTX CIDARA THERAPEUTICS INC | 0.3% | $1.3m | 47,642 | – | new | |
| 47 | ATYR ATYR PHARMA INC | Healthcare | 0.2% | $725.7k | 200,475 | – | new |
| 48 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.1% | $435.6k | 9,434 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.